Further, hematoma components such as erythrocyte lysis products are key modulators of brain inflammation and among the pro-inflammatory cytokines, IL-1β is considered as a pivotal inflammatory target after ICH (Masada et al., 2001; Lok et al., 2012). The gene discussed is IL1B; the disease is hematoma.